$NBS MLV Reduces Neostem Price Target As NBS10 Shows A Mortality Benefit But May Require Further Study http://www.smarteranalyst.com/2014/11/18/mlv-maintains-buy-on-neostem-shares-sees-176-upside-for-the-stock/